Sintx Technologies (NASDAQ:SINT) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 76,300 shares, a decrease of 70.0% from the July 31st total of 254,300 shares. Based on an average trading volume of 751,100 shares, the short-interest ratio is currently 0.1 days. Currently, 3.9% of the shares of the stock are sold short.
NASDAQ SINT traded down $0.11 during trading hours on Friday, reaching $2.01. 4,966 shares of the company’s stock were exchanged, compared to its average volume of 1,835,548. Sintx Technologies has a one year low of $1.25 and a one year high of $12.30. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.30 and a current ratio of 2.34.
Sintx Technologies (NASDAQ:SINT) last released its quarterly earnings results on Thursday, August 15th. The company reported ($3.99) EPS for the quarter. The company had revenue of $0.17 million during the quarter.
Separately, Ascendiant Capital Markets began coverage on Sintx Technologies in a research report on Wednesday. They set a “buy” rating and a $3.00 price target on the stock.
Sintx Technologies Company Profile
Sintx Technologies, Inc, a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications.
Featured Story: What is required to own or exchange cryptocurrency?
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.